MDS: Treatment paradigms are changing

Syndicated Studies, Oncology

MyeloDysplastic Syndromes: our syndicated research will tell you why - and how - treatment paradigms are changing. Our results from first 2 waves conducted are available now and field is running for the 3rd wave. 

AplusA 30+ years Anniversary - Interview #2

AplusA News

The second interview with our AplusA employees is here!

This year, AplusA is celebrating its 30+...

AplusA Anniversaire 30+ ans - Interview #2

AplusA News

La deuxième interview de nos collaborateurs AplusA est là !

En 2021, AplusA fête - non pas ses...

Social Media Listening, Intelligence, Monitoring; What difference does it make?

Digital, Social Media Listening

Social data analytics, social media researchonline market research, social media listening, ...

Index de l'égalité professionnelle Femmes / Hommes 2020

AplusA News

Consciente de l’importance que représente la mixité professionnelle, qui est un facteur...

How can you benefit from new market opportunities in OTC after the shock of covid-19?

COVID-19, OTC

All of our countries implemented sanitary measures for stopping the global Covid-19 pandemic:...

AplusA 30+ years Anniversary - Interview #1

AplusA News

In ‘21, we are celebrating our 30+.

AplusA is actually 30+ years old this year... But what does...

AplusA Anniversaire 30+ ans - Interview #1

AplusA News

C’est l’année 21, mais nous en célébrons plus de 30.

En 2021, AplusA fête - non pas ses 30 -...

Our brand new 2020 Syndicated Surveys

COVID-19, Syndicated Studies

Our range of syndicated studies now covers over 30 indications, many of them with results...

COVID-19 2nd Phase - Impact on Physicians’ Practice - Syndicated Study

hemato-oncology, COVID-19, Syndicated Studies, Oncology

How does COVID-19 affect the HCPS relationships with patients and with the pharmaceutical...